Gene Editing Technology

Cibus Reports Q4 2024 Financials & Business Update

Cibus, Inc. (Nasdaq: CBUS), a biotechnology firm specializing in gene-edited plant traits, announced its financial results for the quarter ended December 31, 2024, and provided a comprehensive business update.

Read More

genXtraits & Solis Agrosciences Partner to Accelerate Crop Development

genXtraits partners with Solis Agrosciences to create & commercialize novel crop varieties or license them to seed companies.

Read More